Overview

Study In Patients With Insulin Resistance

Status:
Completed
Trial end date:
2003-08-01
Target enrollment:
Participant gender:
Summary
Fluid management study in patients with insulin resistance.
Phase:
Phase 3
Details
Lead Sponsor:
GlaxoSmithKline
Treatments:
Insulin
Rosiglitazone